Strong Industry Profiles Join Inceptua

PR75024

LUXEMBOURG, Sept. 5, 2018 /PRNewswire=KYODO JBN/ --

    Key appointments strengthen full lifecycle support for pharma

    Inceptua Group (previously Multipharma) today announces the strengthening

of its Commercial, Strategy, and Supply Chain teams as industry leading experts

Bodil Jonason, Jeremy Broadis, Mark Ware, and Annika Kollen join the company.

Logo:  https://mma.prnewswire.com/media/739136/Inceptua_Group_Logo.jpg

    "Inceptua is further developing our platform as the partner of choice for

pharma and biotech companies commercializing niche and specialty pharma

products. We are able to assume partial or full product responsibility, and our

offering spans the life-cycle, from pre-approval to product launch and the

successful marketing of speciality products. The recruitment of these industry

experts augments our position within the areas of Clinical Trial Services,

Medicines Access, and Commercial Products and underlines Inceptua's drive to

provide market leading service throughout the product journey," says Alan

Raffensperger,  CEO, Inceptua Group.:

    Bodil Jonason joins as Head of Marketing & Sales for Commercial Products.

Bodil is an expert in launching, life cycle management, and commercialization

of specialty, rare, and orphan products who joins Inceptua from a role as Vice

President at Sobi (Swedish Orphan Biovitrum AB) where she led the Specialty

Care unit. Her previous role also included responsibility for the partner

product portfolio, making her an experienced alliance partner for companies who

wish to launch and commercialize products globally or in selected markets.

    Jeremy Broadis has been appointed Vice President, Business Development,

Commercial Products. Jeremy has a long and successful track record in assisting

companies in bringing their products to patients in key new markets through

innovative strategic partnerships.  Jeremy is joining Inceptua from IQVIA

(Quintiles) where he was responsible for pan-European specialty products

commercialisation. Jeremy also has a background in risk-based transactions

(NovaQuest) and healthcare consulting (ZS Associates).

    Mark Ware has been appointed Vice President, Strategy for the Inceptua

Group and brings over 20 years' experience in the pharma industry, having

worked for Pharma companies, consulting firms and Pharma service providers. His

areas of expertise include business development, comparator sourcing, clinical

trial supplies, comparator procurement strategy, and preapproval access

programs. He has a record of driving growth and most recently lead the Clinical

Trial Service teams at Idis and Clinigen.

    Furthermore, Inceptua has appointed Annika Kollen as Vice President, Head

of Global Supply Chain for the Inceptua Group. Annika is joining Inceptua from

a role as Head of Global Supply Chain at Sobi. Annika has significant

experience and is considered a leading industry expert within international

supply chain management.

    "With Bodil Jonason's, Jeremy Broadis' and Mark Ware's experience, broad

knowledge, and appreciated leader-ship skills, we add to our team three of the

industry's leading experts to manage our commercial and strategic efforts. Our

supply chain set-up has always been one of our key strengths, and with Annika

Kollen joining, we will continue to provide our clients with a best-in-class

service and cutting-edge supply chain solutions," says Alan Raffensperger.

    For further information, please contact:

    Inceptua Group Communications

    Miranda McLaughlan, Communications Manager

    Phone: +49-30-1202-1353

    E-Mail: miranda.mclaughlan@inceptua.com

Source:  Inceptua Group